Imran Nasrullah, Vice President & Head, Open Innovation Center North America - East at Bayer Pharmaceuticals
Imran is responsible for forging business relationships within the Boston/Cambridge life-science ecosystem among venture capital, family funds, angel investors, academia, biotech and other stakeholders. He brings over 20 years of life sciences business development, intellectual property and licensing, and policy experience. Previously, at Boehringer Ingelheim Pharmaceuticals (BI), Imran created and oversaw several novel programs centered on business mentoring and early technology access, and was awarded BI’s President’s Award. Imran also founded MassConnect & Pharma Days, while the CBO of MassBio. He also has experience working for blue chip organizations like Millennium Pharmaceuticals (now Takeda) and Genzyme Genetics (now LabCorp), as well as Mayo Clinic and Dana Farber Cancer Institute. He holds a B.S. from the University of Massachusetts, a M.Sc. from the University of Colorado and a J.D. from Suffolk University Law School.